| Turchia | Austria | Spagna | |
| Tomoterapia | da $12,000 | da $30,000 | da $35,000 |
| Terapia ormonale | da $404 | da $7,000 | da $3,000 |
| Terapia di deprivazione androgenica | da $1,500 | da $4,500 | da $3,200 |
| Terapia con protoni | da $70,000 | da $80,000 | da $25,393 |
| Sistema robotico Da Vinci | da $9,500 | da $22,000 | da $17,000 |
Il Prof. Galceran dirige l'Unità di Cancro Genitourinario della Spagna presso il Vall d'Hebron, specializzandosi nel cancro alla prostata con oltre 900 procedure e sperimentazioni cliniche nazionali.
Dr. Antonio Alcaraz is a Spanish uro-oncologist and transplantologist with over 30 years of experience and 500 successful operations, specializing in the treatment of prostate cancer, kidney, bladder, and other urogenital system pathologies using minimally invasive and robotic systems, as well as congenital pathologies in children. He is a member of several prestigious urological societies.
Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.
He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.